LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the risk for bleeding, report trial investigators. The randomized controlled POPular PAUSE TAVI trial presented at the European Society of Cardiology Congress showed that patients randomly assigned to continuous …
